Brief: Microbix sues Novartis for infringing virusmax� patent
06/01/2014 22:00
Jan 6 (Reuters) - Microbix Biosystems Inc MBX.TO : * Press release- Microbix sues Novartis for infringement of its virusmax� patent * Says commences patent litigation against Novartis vaccines and diagnostics alleging infringement of virusmax technology * Source text for Eikon ID:nCNWpDscWa * Further company coverage MBX.TO ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Microbix Biosystems
See all newsCanada's Microbix Q3 revenue rises on higher antigen, QAPs sales
Brief: Microbix Biosystems Q3 Revenue CAD 4.1 Million
Canada's Microbix Biosystems Q2 revenue falls 37% on weaker China sales
Canada's Microbix Q1 revenue down 30% on China sales decline
Brief: Microbix Biosystems Q1 Revenue CAD 4.2 Million